← All articles

Body and movement2 min read

GLP-1 plateau: why your weight stops going down and what to watch

Weight stopped going down? A plateau is common on GLP-1 treatment. Learn why it happens, how to read your weekly trend and what to bring to your appointment.

Why your weight stops going down

Weight loss on treatment tends to be faster at first and then slow down. In the large studies of semaglutide and tirzepatide, the average curve gradually approaches a plateau over time. Part of the explanation is simple: a body that weighs less uses less energy to function.

Each person levels off at their own point, and the response varies a lot from one person to the next. Study averages describe groups, and they’re not a promise for any one person.

Early on, a stalled scale isn’t a plateau yet

In the first weeks, on the starting doses, weight loss tends to be small. Those doses are there so your body can get used to the medication. A slow start doesn’t mean the treatment won’t work: it’s the adjustment phase, not a plateau.

What to watch

When your weight seems stuck, these are the things that help you understand what’s going on:

  • The trend over weeks, not the number of the day. Weight can swing up to about 1 kg (2.2 lb) from one day to the next without any change in fat, and a single uptick isn’t a plateau.
  • How you weigh yourself. At the same time of day and under the same conditions, the line becomes more reliable.
  • Consistency. In digital care programs, logging weight once a week, regularly, went hand in hand with staying on treatment longer. These are observational studies: they show an association, not cause and effect.
  • Protein, sleep and strength training. These are the things worth reviewing with the people who care for you when your weight stalls.

What stays with your care team

Feeling that the treatment isn’t working is one of the reasons most closely tied to giving it up. If the plateau is getting you down, that’s also something to bring to your appointment: the people who care for you can help you find a way forward.

Your dose is a decision for the person who prescribes it. We don’t suggest raising or lowering it, and any change to your treatment is a conversation with your care team.

In Morphi

We show weight, waist and measurements in charts of your trend over weeks, not one day’s swing. The one-page summary brings that progress, along with your doses and symptoms, to your appointment.

Sources

Written by the Morphi team from these sources, the same ones Morphi Intelligence uses. It is not a medical review and does not replace advice from your care team.

  1. Wilding J. P. H. et al. New England Journal of Medicine, 2021.
  2. Jastreboff et al. New England Journal of Medicine, 2022.
  3. Horn D. B. et al. Clinical Obesity, 2025.
  4. Ard J. et al. Diabetes, Obesity and Metabolism, 2025.
  5. Edholm O. G. et al. British Journal of Nutrition, 1964.
  6. Talay et al. Healthcare, 2025; Talay et al. Diabetes, Obesity and Metabolism, 2026.

Morphi doesn’t replace your doctor’s guidance and isn’t for emergencies. Any change to your treatment is a decision for the two of you.

Updated

Download Morphi

Start today, at your own pace

Download now and do your first check-in in under a minute.